.............................. The Manitoba Pharmaceutical Association NEWSLETTER OFFICERS Pat Trozzo, President, Winnipeg Penny Murray, Vice President, Winnipeg Rob Jaska, Executive Treasurer, Brandon Gary Cavanagh, Past President, Brandon COUNCILLORS Kelly Borisenko, Winnipeg Shawn Bugden, Morden Wendy Clark, Carman Ron Kozak, Minnedosa Randall Stephanchew, Winnipeg David Collins, Dean, Faculty of Pharmacy LAY MEMBERS Sheila Holden John Rodie LIAISON MEMBERS Kyle MacNair, C.S.H.P. (MB. Branch) Courtney Marion, Student Liaison Scott Ransome, M.S.P. Liaison Gail Keeley, Government Liaison ASSOCIATION STAFF Ronald Guse, Registrar Susan Lessard-Friesen, Assistant Registrar Ross Forsyth, Assistant Registrar Dexter Boyd, Assistant Registrar Judy Higham, Executive Assistant Bev Robinson, Administrative Assistant Kathy Cobb, Professional Development Secretary Pamela Gordon, Administrative Secretary V I S I O N Excellence in Pharmacy Practice M I S S I O N To protect the health and well being of the public by ensuring and promoting safe, effective and progressive pharmacy practice. V A L U E S The MPhA activities are based on the following values and are the foundation of what we do: ~ Integrity ~ Respect ~ Excellence ~ Accountability ~ Collaboration ~ Life Long Learning 187 St. Mary s Road, Winnipeg, Manitoba, Canada R2H 1J2 Telephone (204) 233-1411 Fax (204) 237-3468 Email: info@mpha.mb.ca Website: www.napra.ca.............................. From the Council Meeting of February 12, 2007 COUNCIL: Passed a motion approving the development of the computer program and database, to a maximum of $5,000.00 in order to provide pharmacist data to CIHI. Passed a motion approving the Preceptor Application. Congratulated Gary Cavanagh on his new appointment as President of PEBC (Pharmacy Examining Board of Canada) taking effect February, 2007. Passed a motion that Pharmacy Graduation Breakfast be held on June 7, 2007 on the same day as the Faculty of Pharmacy convocation day. The 2007 Manitoba Pharmacy Conference included in this mailing The 2007 Manitoba Pharmacy Conference April 14, 2007 Annual General Meeting Agenda & Notice of Meeting Request Form for 2007 Annual Reports NAPRA Notes will be held at the Victoria Inn 1808 Wellington Avenue Winnipeg, Manitoba April 13th to 15th, 2007. Please watch for further information in the mail or you can visit www.mbpharmacyconference.com Masters Degree Opportunity - March 30th, 2007 deadline Medication Safety Alerts - Volume 1, Issue 1, January 2007 Canadian National Drug Scheduling System - March 2007 ONE......................... 1
MANITOBA PHARMACY CONFERENCE 2007 Please be advised the Annual General Meeting of the M.Ph.A. is scheduled for Saturday, April 14, 2007 at the Victoria Inn 1808 Wellington Avenue, Winnipeg, Manitoba 10:30 a.m. to 12:00 p.m. - Centennial Room MANITOBA PHARMACEUTICAL ASSOCIATION ANNUAL GENERAL MEETING The Annual General Meeting of the Manitoba Pharmaceutical Association is scheduled to commence at 10:30 a.m. at the Victoria Inn, 1808 Wellington Avenue, in Winnipeg, at which time a series of annual reports will be presented. The reports will be presented for information and any issues arising from the reports will be referred to the Issues Forum, which will occur in the afternoon. Please be advised that members will have an opportunity to discuss issues at the issues forum and any proposed changes to the regulations or bylaws at special general meetings leading up to the annual general meeting. A G E N D A - O R D E R O F B U S I N E S S CHAIR - PAT TROZZO 1. Reading of the minutes of the 2006 Annual General Meeting, Registrar 2. Reading of the minutes June 19, 2006, Special General Meeting, Registrar 3. Reading of the minutes November 22, 2006, Special General Meeting, Registrar 4. Business arising from the minutes 5. Report of Executive Treasurer 6. Registrar's Report 7. President's Address 8. Committee and Liaison Reports (passed for information as a group) 9. Faculty of Pharmacy Report and Notice of Motion Notice of Motion: Penny Murray will move or cause to be moved, seconded by Gary Cavanagh That M.Ph.A. support the continuation of the $100.00 levy, per member's annual license fee, to the Faculty of Pharmacy, University of Manitoba, for 2008 licensing year. 10. Unfinished Business 11. New Business The Order of Business is designed to allow the formal Annual General Meeting to complete its mandate of closing the dealings that have been completed for the previous fiscal year. Reports are to encompass that fiscal year only. Those issues requiring detailed discussion or where resolution cannot be established will be forwarded to the Issues Forum to be held at the Manitoba Pharmacy Conference. 2.......................................
Annual General Meeting ~ Rules of Procedure 1. A Notice of Meeting will be forwarded to the entire membership no less than 21 days prior to the scheduled meeting. 2. A quorum must be present to hold a meeting. Must be at least 5% of the membership in attendance. 3. A Parliamentarian will assist with parliamentary procedure as the need arises. 4. Roberts Rules of Order will govern. 5. The chair of the general meeting may permit discussion of motions that are for information and do not require action by the Association. Motions either simple or by resolution, accepted at an annual general meeting, or a special general meeting, requiring action on behalf of the Association shall be forwarded to Council for consideration and decision. 6. All members must sign the attendance sign-in sheet. 7. Voting cards will be issued to all voting members. 8. All members may speak only once to any given resolution and debate may be limited, unless permission to the contrary is given by the assembly. 9. All members are requested to speak at the microphone and are further requested to identify themselves by name before speaking. 10. The mover and seconder can speak first, followed by other speakers. The mover has the option of being the last speaker to the motion. 11. Speakers must address the chair. 12. All members present are encouraged to engage in discussion, but only voting members may make motions and vote. 13. Members who hold some type of membership with the Manitoba Pharmaceutical Association other than a practicing licence in a patient care or a non-patient care setting, are entitled to speak but not vote. 14. Non-members and observers are welcome but are unable to engage in discussion or vote. 15. Motion forms will be provided. Motions should be in writing on these forms and the appropriate copy given to the chair at the time of making the motion. 16. During voting on motions, members are to remain in the meeting room. In keeping with Motion #10 of the June 16, 2002 Special General Meeting Minutes, the above set of rules of procedures has been compiled for the membership's information and this basic set of procedures will be made available at every Annual General Meeting and Special General Meeting so the membership can effectively proceed with the meeting on a timely basis. ONE....................................... 3
..................................................................................... MANITOBA PHARMACY CONFERENCE 2007 The Changing Face of Pharmacy AWARDS PRESENTATION Annual Awards Banquet Saturday, April 14, 2007 6:00 p.m. Reception 7:00 p.m. Dinner 9:00 p.m. Awards Presentations Recipient of the Wyeth Consumer Healthcare Bowl of Hygeia - Ms. Lori Dangerfield, Brandon, Manitoba This award is given annually in appreciation of the time and personal sacrifice devoted by pharmacists to the welfare of their respective communities. In 1958 E. Claiborne Robins, President of A.H. Robins and a third-generation pharmacist in his family, established the Bowl of Hygeia Award for outstanding community service by pharmacists. The award, an impressive mahogany plaque that features the Bowl of Hygeia cast in bronze, is presented annually to a recipient selected by each of the participating pharmaceutical associations. Lori Dangerfield is the recipient of this year's Bowl of Hygeia Award. Lori has been involved locally and provincially with The Brandon YMCA Board of Directors, The Brandon Economic Development Board, Volunteer for the Scott Tournament of Hearts Committee, the 1997 Canada Summer Games Medical Committee, a Director and President of the Brandon Chamber of Commerce, a member of the Provincial Exhibition, a Manitoba Cancer Treatment and Research Foundation Board Member, Preceptor for Pharmacy Students, member of the M.Ph.A. Professional Development Committee and member of the Brandon Curling Club. Lori has been called upon by the business community and community at large to deal with pressing community issues that affect Brandon from time to time. In the past she has been a chair of the CFB Shilo Task Force which lobbied successfully for the retention of the Shilo military base. Most recently, she was a member of the Brandon Economic Strategic Action Plan which was a committee hand picked by Brandon City Council charged to formulate a Plan of Growth for Brandon. Ms. Dangerfield is widely respected for her involvement and her leadership in community affairs and has been active recruited to let her name stand in municipal and provincial elections. She is an outstanding example of community involvement and professionalism and very deserving of this Award. Recipient of the 2006 Pharmacist of the Year Ms. Lois Cantin, Winnipeg, Manitoba This award is given annually to a Manitoba Pharmacist who, in the opinion of his/her peers, has made a significant contribution to the profession during his/her career. Lois Cantin entered the Faculty of Pharmacy in October 1969 in a whirlwind after having made a tremendous personal decision to leave the Canadian National Ski Team. She contributed to the faculty through participating in all student activities and ultimately graduated in 1973. Lois' experience in pharmacy has a broad jurisdiction, working in retail pharmacy at McKnights Tuxedo Park Pharmacy for 4 years, and then embarking on a hospital pharmacy career as Pharmacy Director at Portage General Hospital. In 1981, Lois moved to Flin Flon and following a 10 week locum and a one year position, remained there as Director of Pharmacy for the Nor-Man Regional Health Authority. She moved to Winnipeg in 2006 where she is Pharmacy Director at Concordia Hospital Pharmacy. Lois served on M.Ph.A. Council for from 1994 to 2006, and served as the first female President in the history of the Manitoba Pharmaceutical Association from 2002-2004. Improved Professional Development and Professional Competency, Patient Safety, Health Care Reform, development of meaningful relationships with members of government, strategic planning and accountability are but a few of the daily activities of Lois through her term as President of the M.Ph.A. continued next page... 4
She continues to sit as the Chair of the M.Ph.A. Discipline Committee. Lois was on the Executive Committee of the National Association of Pharmacy Regulatory Authorities (NAPRA) for several years, serving as President in 2005. Lois was also on the Executive Committee of the Norman Regional CQI Committee, Past-President of Manitoba Association of Pharmacy Directors, CSHP - Northern Liaison, Cancer Control Committee member, Pharmacy Staffing Guidelines Committee, MHO Group Purchasing Committee, Regional Continuing Education Co-ordinator, as well as other committees of the Flin Flon Hospital and NorMan Regional Health Authority. Her firm belief, and commitment of Council to protect public safety, resulted in the M.Ph.A. receiving the Fred T. th Mahaffey Award at the 100 Anniversary Annual General Meeting of the National Association of Boards of Pharmacy (NABP). This award recognizes a member board of pharmacy 'that has substantially contributed to the protection of the public health and welfare through the enforcement of state and federal laws, regulations and the advancement of NABP's goals and objectives as specified in the Constitution and Bylaws. M.Ph.A. was the first and only Canadian organization to be honored with this award and Lois was in the forefront of making this possible. Her energy is boundless and her dedication unsurpassed. Factored in with her strong community involvement through the presidency of her local soccer club, Board member of her sons' schools and coach of many and varied sports activities. AWARD PRESENTATIONS M.Ph.A. Awards Luncheon Sunday, April 15, 2007 12:00 Noon HONORARY LIFE MEMBERS Recipient of an Honorary Life Membership Mr. Darryl Darling, Brandon, Manitoba The recipient of this award is open to pharmacists who have made a significant contribution to pharmacy in Manitoba and the national level. Darryl Darling graduated with a Bachelor of Science in Pharmacy in 1961 from the University of Manitoba. He worked for Johnstons Drugs in Brandon from 1961-1980, Clinic Pharmacy in Brandon from 1980-1990, was Manager of Canada Safeway Pharmacy from 1990-2000 and was employed by Minnedosa Hospital Pharmacy from 2002-2004. Darryl's professional activities included: Manitoba Pharmaceutical Association Member from 1961 to 2006, Regional Organizer for Continuing Education in Western Manitoba from 1978 to 1983. Darryl was elected to M.Ph.A. Council in 1982 and served as President from 1988 to 1990. He was Chair of the M.Ph.A. Bylaws Committee that commenced rewriting the Manitoba Pharmaceutical Act. He served as a member of the Faculty Council of the University of Manitoba, was a member of the Student Admissions Committee of the University of Manitoba, and Chair of the M.Ph.A. Honors and Awards Committee. He was a Member and supporter of the Manitoba Society of Pharmacists from 1973 to present. He was an active member of the Canadian Pharmaceutical Association from 1985 to 1993, serving as a speaker of th Council of Delegates in 1993. Darryl has been very active in his community since 1958 and some of his most recent involvements have been the 2006 Special Olympics (Medical Services) held in Brandon 2004-2006, The First Chair of the City of Brandon Crime Prevention Committee formed in 2006, Chair of the Board of Directors of Seniors for Seniors and was actively th involved in the University of Manitoba 100 Anniversary celebration from 1997-1999. continued next page... ONE....................................... 5
..................................................................................... AWARD PRESENTATIONS (continued) M.Ph.A. Awards Luncheon Sunday, April 15, 2007 12:00 Noon HONORARY LIFE MEMBERS Recipient of an Honorary Life Membership Mr. Ernest Stefanson, Gimli, Mantioba The recipient of this award is open to pharmacists who have made a significant contribution to pharmacy in Mantioba and the national level. Ernest Stefanson was born and raised in Gimli, Manitoba. He attended the University of Manitoba Faculty of Pharmacy and was Senior Stick in his final year. This was the class of 1968 which produced many pharmacy leaders in Manitoba. Ernest worked as a staff pharmacist at the Winnipeg General Hospital, now the Health Sciences Center, and then moved back to Gimli to open Viking Pharmacy in January 1969. Ernest became a Board member of the Manitoba Society of Pharmacists and was President from 1980-1983. In 1986 he joined the Canadian Pharmaceutical Association's Board of Directors as the representative for Manitoba. He served on numerous committees, including being Chairman of PACT$ (Pharmacists Against Cigarette and Tobacco Sales) 1987-1990. This was due in large part to his decision to stop selling tobacco products in his store in April 1984. He was a member of the Review, Evaluation and Planning Committee on CPhA's Task Force on Roles and Structures. He was Finance Chair from 1989-1992 and was elected Western Vice President from 1989-1992. Ernest served as President of CPhA in 1992-1993. He also served as Chairman of the Canadian Pharmaceutical Journal Editorial Advisory Committee from 1994-1998. In 1991 Ernest joined the Pharmasave organization and has been active in their governance. He served both regionally and nationally on numerous committees and was Chairman of the national board in 1998-1999. Ernest has also been involved in international pharmacy organizations. He was the Canadian delegate to FIP for 2 years and served on their Community Practice committee. From 1994-1999 he was the Canadian delegate to the Commonwealth Pharmaceutical Association's America's Region, which encompasses Canada and the Caribbean. He was elected to the CPA executive from 1995-1999 as the America's Region representative. During this time he was asked to speak at conferences in Zimbabwe, Australia and Zambia. Ernest has also been very involved in his own community. He has been a Board member of the Betel Home Foundation from 1970 to present and is a past president. He has been president of the Gimli Chamber of Commerce on two separate occasions. He is a long standing member of the Icelandic Festival of Manitoba and a past president, and a past president of the Gimli Kinsmen Club. He is an Honourary Life Member of both these groups. Ernest is currently chairman of the Betel Heritage Foundation which operates a 55 unit seniors housing complex and Icelandic cultural center in Gimli. Ernest was Manitoba's Pharmacist of the Year in 1990, received the Canadian Pharmacists Association's Meritorious Service Award in 1998 and was the Bowl of Hygeia winner in 1999. 50 Year Gold Pins to the Class of 1957 John Allen George Goldhawk Edward Kavalec 25 Year Silver Pins to the Class of 1982 Blaire Cairns Linda Foley Gilbert Leung Norma Peckover Lois Clark Lorraine Graham Laureen Lipinski Joan Peel Wayne Currah Claude Grimard Elizabeth Locke John Pelletier Maria Da Silva Gregory Harochaw Marilyn Louie Mervin Pichlyk Peter Danakas Barbara Kreml Brenda McLeod Charles Scerbo Lori Fasano 6
IPS Pharmacy Update: Filling Co-signed Prescriptions MPhA is advising all members of the current situation in the on-going debate regarding co-signed prescriptions. It is important that all pharmacists be made aware of this matter so they can appreciate their obligations in practice. The MPhA has provided information and direction throughout the last four years regarding the co-signing issue. Legal counsel representing some IPS Pharmacists have argued that a pharmacist who fills a prescription cannot have an obligation to know whether the prescriber has complied with his or her standards of care when issuing the prescription. The MPhA has maintained that it is a matter of patient safety, and in circumstances where a pharmacist knows or ought to know the prescription is inappropriate, in spite of meeting the written requirements and mechanics of a prescription, the prescription should not be filled. The regulatory bodies for the medical profession in all Canadian provinces have now passed rules which in effect declare that the practice of co-signing a prescription without a physician having examined the subject patient is unacceptable practice. As a result of these rules, the licensing bodies for physicians in British Columbia, Saskatchewan, Manitoba, Ontario, Quebec and New Brunswick respectively have formally disciplined physicians for co-signing prescriptions without having had direct patient contact or without having examined the patient. MPhA has already provided this information to all IPS pharmacy managers and license holders. The written notice to IPS pharmacies went on to state a pharmacist who fills a prescription that has been co-signed by a physician, whom the pharmacist knows or ought to know, has not seen the patient and that physician is licensed in British Columbia, Saskatchewan, Manitoba, Ontario, Quebec and/or New Brunswick, that pharmacist's conduct could be referred to the Complaints Committee of MPhA for investigation. The referral to the Complaints Committee may in turn result in a referral to the Discipline Committee. If any other Canadian licensing bodies discipline physicians for such conduct in the future, the IPS pharmacies will be so advised by MPhA. Practice Advisories for Patient Safety Part of the Council's commitment to enhance the quality of care and patient safety in Manitoba pharmacies was to instruct the Chair of the Complaints Committee to issue a report following meetings of the Committee. The intention of the information is to inform pharmacists of medication incidents thereby providing an opportunity to relate and reflect upon their practice. Offering to Counsel does not meet the Standards A far too common reported component of complaints investigations alleging a medication error is the failure to counsel the patient about the medication being given. The Standards of Practice are clear, pharmacists must counsel the patient prior to the release of the prescribed medication. This includes all new and refill medications. The difference being the pharmacist has some discretion as to the information covered during the refill counselling session. Offering to counsel by the technician or another staff person does not meet the standard. Not only does patient counselling meet the requirements of the standards and provides important knowledge and information to the patient, but the show and tell process becomes the ultimate final check and presents an opportunity for the patient to question Why do those tablets look differently? A recent medication error investigated by the Complaints Committee was propagated by the technician offering the patient the opportunity to speak with the pharmacist when issuing a refill of their medication and the patient declining. What happens in your practice? In Memoriam Roman (Roy) Bilous (Honorary Life Member) ~ February 17, 2007 ~ ONE....................................... 7
Pharmacy Technicians: Update on current status and coming changes nationally and provincially There is a lot of activity nationally regarding pharmacy technicians. The recent NAPRA (National Association of Pharmacy Regulatory Authorities) Notes bulletins (also included with this newsletter) have kept pharmacists informed about national efforts to review the feasibility of administering a national registration process for pharmacy technicians and the development of national competencies for Canadian pharmacy technicians at entry to practice. NAPRA has done an extensive literature review of existing competencies and guidelines. The Pharmacy Examining Board of Canada (PEBC) has been hired by the Ontario College of Pharmacists (OCP) to develop an entry-to-practice examination. Although the OCP has called this a national examination, any development would have to be based upon nationally approved competencies before it could be considered national. Throughout Canada, provincial pharmacy licensing authorities are reviewing the issues of definition, role and registration of pharmacy technicians. The Canadian Council for the Accreditation of Pharmacy Programs (CCAPP) is preparing for their role in the accreditation of Pharmacy Technicians programs based upon the nationally approved competencies. Clearly, the development of national competencies is critical and NAPRA has taken a lead role. At the end of February, NAPRA, through the work of the member provinces and the National Advisory Committee on Licensing (NACL), drafted entry to practice competencies for pharmacy technicians that will be forwarded to external stakeholders for review and feedback. At the April NAPRA Board meeting, these competencies will be presented for approval. The status of pharmacy technicians in Manitoba remains the status quo, as under the existing Pharmaceutical Act and regulations. Presently, there is no definition or qualifications for pharmacy technicians and pharmacist to technician ratio remains in effect. Bill 41: The Pharmaceutical Act does allow for the regulations to describe the extent by which pharmacy technicians can engage in the practice of pharmacy (3(2)) and the establishing the qualifications, experience and other requirements that must be held by a pharmacy technician (73(1h)). The regulation development process has already been initiated, as announced in the last newsletter. It is the intention of Council to include a definition of a pharmacy technician in the regulations and a description of the tasks and circumstances under which tasks can be delegated. Subject to the approval of the Minister, the decision regarding how regulations will define technicians and their role in pharmacy practice, will rest with the Pharmacists of Manitoba. Clearly, it is important for Manitoba to participate in the national activity regarding the definition and role of the pharmacy technician and the melding of this activity into the provincial regulations. This is indeed exciting times. However, the important message is not to have the current practice evolve in advance of the regulations. The ratio and the role of the pharmacy technicians in Manitoba Pharmacies must reflect the present act and regulations. Umbrella Legislation: Health Profession Regulatory Reform Initiative The Government of Manitoba and Manitoba Health continues with the development of umbrella legislation under the "Health Profession Regulatory Reform Initiative (HPRRI). There have been a couple meetings of the regulated health professions within the province and a website has been developed for this activity (www.gov.mb.ca/health/hprri/index.html) The first area of legislation to be drafted and developed are the Complaint and Discipline process. The working template will be the Dental Hygienist Act. MPhA was asked for comments in comparing this act to Bill 41: The Pharmaceutical Act. Clearly, there are many similar areas, but there are important differences as well. The other task assigned to the regulated health professions group is the development of a list of restricted activities, or as in Manitoba Health's terms reserved actions. This format of health discipline legislation using reserved actions is similar to British Columbia and Alberta and can be viewed at those respective provinces' government websites. 8 ONE.......................................
Amendments to Federal Drug & Health-Related Products Legislation And Recommendations Made By the National Drug Scheduling Advisory Committee (NDSAC) on Amendments to the National Drug Schedules The federal Acts and Regulations relevant to the distribution of drugs and other health-related products, such as the Controlled Drugs and Substances Act & Regulations and the Food and Drugs Act & Regulations, may be found on the NAPRA website (napra.ca) under Federal Legislation. This section of the NAPRA website also includes excerpts from the federal government's website describing amendments to this legislation that have been proposed, those that are currently pending (Canada Gazette, Part I) and those amendments that have been recently approved (Canada Gazette, Part II). When an amendment to federal legislation is proposed, there is a consultation period established in which pharmacists, other interested health professionals and the public may comment on the proposed amendment. In a similar manner, when NDSAC makes recommendations regarding amendments to the National Drug Schedules, there is a consultation period provided in which interested parties may make comment for consideration by the NAPRA Board prior to approval of the amendment. For a listing of the NDSAC recommendations currently pending and information on how you can provide comments, please refer to the National Drug Schedules section of the NAPRA website (napra.ca) under the Notice Board. THIS NEWSLETTER is forwarded to every licensed pharmacist in the Province of Manitoba. Decisions of the Manitoba Pharmaceutical Association regarding all matters such as regulations, drug related incidents, etc. are published in the Newsletter. The Manitoba Pharmaceutical Association therefore assumes that all pharmacists are aware of these matters. PUBLISHED BY: The Manitoba Pharmaceutical Association 187 St. Mary's Road, Winnipeg, Manitoba R2H 1J2 Phone: (204) 233-1411 Fax: (204) 237-3468 E-mail: info@mpha.mb.ca Nonoxynol-9 Increases the Risk of HIV Transmission / Acquisition In May of 2005 the Centre for Infectious Disease Prevention and Control of the Public Health Agency of Canada released a report on the spermicide, Nonoxynol-9 (N-9) and the risk of HIV transmission. N-9 has long been considered a safe and effective contraceptive method. Recent evidence however, indicates that N-9 may damage both vaginal and rectal cells resulting in lesions, which could facilitate transmission/acquisition of HIV and other blood borne infections. In the case of rectal use, even the single use of a low dose of N-9 may increase the risk of HIV infection by causing disruptions and lesions in the rectal mucosal lining. Therefore, products containing N-9 should not be used rectally nor should they be promoted as a primary means of contraception in women with the potential for frequent usage. As well, products containing N-9 should not be promoted as an effective means for the prevention of HIV or STIs. For the prevention of STIs, including HIV, it is best to use a condom without N-9. Currently in Canada, there are a number of products containing N-9 licensed for use as contraceptives. These products come in a variety of forms, including creams, films, foams, gels and condoms with N-9 lubrication. Pharmacists should remove all N-9 containing products from sale in pharmacies and include information regarding the increased risk of HIV transmission/acquisition with the use of N-9 when counselling clients on safer sex practices. This Public Health Agency of Canada advisory may be found at http://www.phacaspc.gc.ca/publicat/hiv-vihnonoxynol9/index.html....................................... ONE 9
..................................................................................... MPhA Professional Development (PD) Program 2006 Learning Portfolio Summary and Professional Development Log At licence renewal, pharmacists are required to submit their Learning Portfolio Summary and Professional Development Log (PDL) sheets documenting they have met the professional development (PD) requirement for st st the period November 1 to October 31 and listing the accredited and non-accredited learning activities they have participated in during this period. For the 2006 PD Year, pharmacists reported participating in an average of 26 hours (median = 21 hours) of accredited learning activities and an average of 15 hours (median = 10.5 hours) of non-accredited learning activities. In total, pharmacists reported participating in an average of 41 hours (median = 31 hours) of learning activities. These values are similar to those observed in 2005. In addition, the percentage of time pharmacists spent involved in accredited learning activities compared to time spent involved in non-accredited learning activities was similar to that observed in 2005 (57% accredited hours to 43% non-accredited hours). Accredited & Non-Accredited PD Hours 2006 37% Accredited Hours 63% Non-Accredited Hours 2006 Professional Development Hours 700 # of Pharmacists # of Pharmacists 900 800 700 600 500 400 300 200 100 0 600 500 400 300 200 100 0 25 hours >25-35 hours PD Hours 2004, 2005 & 2006 PD Hours 0-15 hours 16-25 hours 36-49 hours > 50 hours 26 to 49 hours = 50 hours 2004 2005 2006 2006 MPhA Learning Portfolio Review Each year twenty percent of all practicing licensed pharmacists are randomly selected to participate in an annual review of their learning portfolios. Pharmacists are selected from the total pool of licensed practicing pharmacists and therefore, pharmacists have an equal chance of selection each year. Those pharmacists that are selected are asked to submit the CEU certificates or other documents supportive of the accredited learning activities listed on their PDLs for review by MPhA staff. The 2006 MPhA Learning Portfolio Review is nearly complete with a total of 233 pharmacists participating in this year's review. We would like to thank all pharmacists for their participation in this annual review process. 10
Pharmacists Awarded Certificates of Achievement The following pharmacists has been awarded a MPhA Certificate of Life Long Learning in Pharmacy in recognition of their outstanding participation in professional development activities during the 2006 PD Year. Recognition is provided each year to pharmacists who have participated in a minimum of 50 hours of professional development activities of which a minimum of 30 hours involve participation in accredited learning activities. Aziz Abdullah Rukhsana Ali Robert Ariano Joanna Ayotte William Balacko Allison Barclay Linda Barnes Eugene Baron Melvin Baxter Allison Bell Tracy Bellyou Marie Berry Venetia Bourrier Shaylene Boychuk Dexter Boyd Alvaro Bras Corinne Brockman Shawn Bugden Patricia Burns Cenzina Caligiuri Lois Cantin W. Gary Cavanagh Patricia Cavanagh William Cechvala Miro Cerqueti Pak-Wai Chan Juanita Chan Arnold Chew Alysha Clarke Jan Coates Ronald Corrigal Marcin Cychowski Tanya Damsgaard Karen DiMarco Betty Dong Erica Dueck Ingrid Dueck Marla Dueck Cecile Dumesnil Brian Dusik Beverly Eros Ronald Eros Janet Evans Raquel Feliciano Rowena Fernando Orysya Fetterly Jonathan Fine Linda Foley Ross Forsyth Chris Franken Claire Gillis Fran Gira Michelle Glass Brent Gray Scott Groen Wafik Gurges Ronald Guse Gregory Harochaw Sylvia Hein Warren Hicks Lorraine Hilderman Kimberly Houssin Ken Humeniuk Denise Hunt S. Kathleen Hunter Chris Johnson Kerry Kent Zahid Khan Ernest Kiz Colleen Kizuik Kulwinder Kler Elmer Kuber Linda Kuber Lisa Lang Alan Lawless Danny Lee Eric Lee Lindsay Lemanski Wilfird Lessak Susan Lessard-Friesen Thomas Ling Danica Lister Abe Loewen Melvin Love Becky Luong Jiang Kyle MacNair Jennifer March Kristopher Marcinowski Tara Jean Martin Gloria Maydaniuk Michael McGillivray Suzanne McKay David McKay Arev Melkon Nancy Metcalfe Julie Mistri Atef Mousaad Penny Murray Mike Namaka Khanh Nguyen Bernadette Ogoms Olasumbo Ojo Annie Ong Marie-Claude Paradis Payal Patel Kristine Petrasko Sig Pfahl Philip Prech Mathilda Prinsloo Colette Raymond Janine Rivest Brenda Rosenthal Shamsul Haque Rustom Barbara Scheuneman Ayman Samuel Heather Saquet Gerri Scott Blair Seifert Trevor Shewfelt Daniel Sitar Glenda Sloane Catherine Smart Tobi Smith Elaine Sniatkowski Cathy Sochasky Barbara Sproll Jen Sterling Alice Studney Roger Tam Jennifer Thackeray Meera Thadani Milien Ting Pat Trozzo Donald Vermette Crystal Vilks Ken Wai Jennifer Wallace Kimberly Watkinson Walter Watral Brooke Wilson Donna Woloschuk Dennis Wong Horst Wuerfel Osama Zaki Lisa Zaretzky Andrew Zubrycki....................................... ONE 11
..................................................................................... Le français suit February 2007 Health Canada Marketed Health Products Directorate / Direction des produits de santé commercialisés Address Locator / Indice de l'adresse: 0701C OTTAWA, Ontario K1A 0K9 ANNOUNCEMENT - MedEffect e-notice The Marketed Health Products Directorate of the Health Products and Food Branch in Health Canada would like to remind stakeholders that by subscribing to MedEffect e-notice, you will receive notices of new safety advisories on health products along with the Canadian Adverse Reaction Newsletter. The e-notices are part of MedEffect, the Health Canada Web site dedicated to adverse reaction information and reporting. Keep Informed: Health Products and Food Branch Santé Canada Direction générale des produits de santé et des aliments Subscribe to Health Canada's MedEffect e-notice mailing list at the following address: www.hc-sc.gc.ca/dhp-mps/medeff/subscribe-abonnement/index_e.html You will automatically receive the most recent Canadian Adverse Reaction Newsletter and health product advisories free by e-mail. Go to www.healthcanada.gc.ca/medeffect to access the MedEffect Canada Web site dedicated to adverse reaction information, including guidelines and forms for reporting suspected adverse reactions. Health Canada also wishes to remind interested parties of the availability of the Guidance Document for Industry - Issuance of Health Professional Communications and Public Communications by Market Authorization Holders (MAH). Health Professional Communications (HPCs) and Public Communications (PCs) are one of the principal means used by industry to communicate new information about the safety of marketed health products to health care professionals and the public in a timely manner. This guidance provides clarification regarding the roles and responsibilities, the issuance process, content and time lines to assist MAHs in developing and disseminating HPCs and their accompanying PCs. This document can be found at the following address: http://www.hc-sc.gc.ca/dhp-mps/medeff/report-declaration/guide/index_e.html The Marketed Health Products Directorate would appreciate your collaboration in communicating this service to interested parties. Canada Developing Educational Programs and Services for Pharmacists on Injection Drug Use and Counselling on Safer Sex Practices: A Brief Survey for Pharmacists There are approximately 50,000 to 100,000 injection drug users of illicit drugs (IDUs) in Canada. In 2005, the Winnipeg Injection Drug Epidemiology (WIDE) study showed that of Winnipeg IDUs, 7% were HIV positive, 32% had experienced hepatitis B infection and 54% had experienced hepatitis C infection. While the majority of IDUs are located in the Winnipeg area, many also live in communities throughout Manitoba. (Details of the WIDE study can be found at http://www.gov.mb.ca/health/publichealth/cdc/surveillance/sns2.pdf ) The MPhA is presently working with the Winnipeg Regional Health Authority (WRHA) Population and Public Health Program to find better ways, through educational programs and services, to help pharmacists across the province provide care to individuals who may be IDUs in their communities. In order to meet the specific needs of pharmacists, we need your help. Please take the next 5 to 10 minutes to complete a brief survey included in this mailing. Your responses will help to identify areas where we can improve our educational programs and services developed for pharmacists on providing care to IDUs and counselling on safer sex practices. This survey may also be completed online by going to the Professional Development section of the MPhA website (go to napra.ca, then MB and then Professional Development). th Please provide your responses by mail, fax (204-237-3468) or online by Friday, April 13, 2007. Thank you for your participation in this survey! 12